Medical Device News Magazine

Edifecs Tops Best in KLAS for CMS Payer Interoperability Category for the Second Year in a Row

Edifecs interoperability solutions enable compliance with CMS Interoperability and Prior Authorization Final Rule

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Edifects

Edifecs, Inc., a global health information technology solutions company, announced today that the Edifecs interoperability platform, XEngine Server for FHIR® and EDI, has been named the market leader for CMS Payer Interoperability for the second consecutive year by KLAS Research in its 2024 Best in KLAS: Software & Services report. Edifecs was ranked as the leader among vendors that provide software designed to meet the requirements for CMS-related payer and state agencies by providing patient access API, provider directory API, and payer-to-payer data exchange. Edifecs topped the list with a score of 92.2, surpassing its own market-leading score of 87.9 in 2023.

Industry Leader

With nearly three decades of experience innovating at scale, Edifecs is the industry leader in helping hundreds of healthcare organizations achieve ongoing interoperability and compliance. Edifecs’ KLAS-award winning interoperability platform now includes the FHIR API for Prior Authorization and EDI capability required to address all components of the CMS-0057-F mandate. The solution is already available to multiple Edifecs customers, giving them a competitive head start on compliance well in advance of the 2026/2027 deadlines.

Best in KLAS Award

The Best in KLAS award furthers Edifecs’ recognition as the market standard for administrative, clinical, and pharmacy interoperability. Additionally, Edifecs is a CMS approved vendor for verifying industry data via its administrative simplification testing tool and the vendor of choice for CAQH for industry operating rules certification.

Venkat Kavarthapu, CEO, Edifecs

“We are honored to be recognized by KLAS for the second year in a row in the CMS Payer Interoperability category. Since our inception, Edifecs has been focused on harnessing data—making sure the data is accessible and accurate, distilling meaning from that data, and ensuring it can be shared and applied when and where it is needed. This deep knowledge makes our platform the proven choice to future-proof capabilities and ease the adoption of new compliance mandates like CMS-0057-F. Our solutions are designed to help successfully manage complexity, increase the ROI of existing core systems, and replace the pervasive friction between payers, providers, and members with collaboration and transparency, enabling the successful adoption of value-based programs. This KLAS award validates our work to catalyze interoperability across the healthcare system.”

Unified Interoperability Solution

Edifecs is uniquely positioned to provide a unified interoperability solution that enables the exchange of any kind of data between partners. Its solution is the gold standard because of its completeness, the richness of its functionality, and the level of support the organization offers. This is a significant differentiator and a major contributor to Edifecs being awarded Best in KLAS for the second year in a row. The Edifecs interoperability platform enables the exchange, unification, and processing of all data including proprietary flat files, healthcare administrative transaction files, pharmacy data, clinical data, and unstructured data. With the Edifecs Cloud, customers are able to increase the ROI of existing IT systems and avoid the costly and disruptive “rip and replace” alternative.

Adam Gale, CEO, KLAS Research

“At KLAS, we firmly believe that the voice of healthcare providers and payers is paramount. The Best in KLAS awards are based on extensive feedback and evaluations from healthcare professionals across the nation. Winning a Best in KLAS award, therefore, is not just about recognition; it shows the trust and confidence that healthcare providers place in the winning vendors. It also helps validate each vendor’s commitment to innovation, quality, and customer satisfaction. We are proud to recognize 2024’s Best in KLAS award winners! Their unwavering dedication to improving patient outcomes is wonderfully inspiring.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”